Calamos Advisors LLC Invests $561,000 in Relx Plc (NYSE:RELX)

Calamos Advisors LLC acquired a new position in Relx Plc (NYSE:RELX) during the fourth quarter, HoldingsChannel.com reports. The institutional investor acquired 12,358 shares of the technology company’s stock, valued at approximately $561,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Venturi Wealth Management LLC boosted its holdings in shares of Relx by 0.9% in the third quarter. Venturi Wealth Management LLC now owns 24,164 shares of the technology company’s stock valued at $1,147,000 after acquiring an additional 214 shares in the last quarter. Ballentine Partners LLC lifted its holdings in shares of Relx by 1.4% during the third quarter. Ballentine Partners LLC now owns 17,306 shares of the technology company’s stock valued at $821,000 after purchasing an additional 240 shares during the last quarter. Marshall Financial Group LLC raised its holdings in Relx by 0.8% during the 3rd quarter. Marshall Financial Group LLC now owns 30,515 shares of the technology company’s stock worth $1,448,000 after buying an additional 246 shares during the period. Procyon Advisors LLC lifted its stake in Relx by 4.1% during the third quarter. Procyon Advisors LLC now owns 6,734 shares of the technology company’s stock valued at $320,000 after buying an additional 265 shares in the last quarter. Finally, Axxcess Wealth Management LLC boosted its holdings in shares of Relx by 5.3% in the third quarter. Axxcess Wealth Management LLC now owns 5,270 shares of the technology company’s stock worth $250,000 after buying an additional 266 shares during the period. 15.02% of the stock is owned by institutional investors.

Relx Stock Up 1.7 %

Shares of NYSE RELX opened at $50.73 on Thursday. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.42 and a current ratio of 0.48. Relx Plc has a one year low of $40.25 and a one year high of $50.84. The business has a 50-day moving average price of $47.25 and a two-hundred day moving average price of $46.89.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Redburn Atlantic initiated coverage on shares of Relx in a report on Wednesday, January 8th. They set a “buy” rating on the stock. StockNews.com began coverage on shares of Relx in a research note on Wednesday, October 30th. They set a “hold” rating on the stock.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.